This cohort study investigates patterns of buprenorphine treatment retention among US youth aged 10 to 18 years from 2015 to 2021. Share: Previous Post Maternal Obesity and Sudden Unexpected Infant Death Next Post Concerns About Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy Related Articles Clinical Practice Guidelines Growth Hormone Use in Childhood and Adult Cardiovascular Disease Clinical Practice Guidelines Deferred Cord Clamping With High Oxygen in Extremely Preterm Infants Clinical Practice Guidelines Vaccination Coverage and Sudden Infant Death Syndrome—Reply Clinical Practice Guidelines Vitamin D Supplementation and Development Among School-aged Children in an Area With Vitamin D Deficiency Clinical Practice Guidelines Delving Deeper Into Maternal COVID-19 Vaccination and Neonatal Outcomes Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.